Projections Research

Projections Research, Inc. (PRI) is a scientific consulting firm that provides clinical pharmacology expertise to the pharmaceutical industry. Its team of scientists uses modeling and simulation to help clients better understand new and marketed drugs, patient responses, and the diseases treatments are intended to address. PRI specializes in population pharmacokinetic and pharmacodynamic (PK/PD) analysis, examining how the body processes a drug and how the drug affects the body, including the influence of patient characteristics, disease status, and co-medications.

The firm’s services include clinical pharmacokinetics, clinical study design, model-based analysis, meta-based modeling, simulations, statistical analysis, and training in modeling and simulation. These methods can help identify suitable dose regimens, assess drug candidates against therapeutic goals, and design informative clinical studies, supporting more timely development decisions and potentially reducing the need for additional trials. PRI reports experience across oncology, virology, cardiovascular, inflammatory, and infectious diseases, as well as pediatric and new-indication extrapolations for biologics and small molecules. The company also notes successful filings with the FDA and EMA.